Document Detail

Management of trauma-induced coagulopathy: trends and practices.
MedLine Citation:
PMID:  20977127     Owner:  NLM     Status:  MEDLINE    
Nearly one-fourth of all trauma admissions present in varying degrees of coagulopathy. According to a US study, 40% of trauma fatalities are due to hemorrhage and hemorrhagic shock, and nearly all patients who are alive when they reach the hospital are coagulopathic when they die. Once coagulopathy develops, patient morbidity drastically increases. Because of the clinical significance of trauma-induced coagulopathy, management strategies to reduce the morbidity and mortality have recently become of interest. This article will review the pathology of trauma-induced coagulopathy and current trends in management, as well as closely examine the data surrounding the use of recombinant factor VII for the treatment of trauma-induced coagulopathy.
Matthew R D'Angelo; Richard P Dutton
Related Documents :
21095427 - Assessment and initial management of urologic trauma.
8401487 - Survey of case manager training needs in traumatic brain injury.
7328687 - Management of frostbite injuries.
17137457 - Tackling the burden of injury in australasia: developing a binational trauma registry.
22711437 - Instruments for geriatric assessment: new multidimensional assessment approaches.
16797687 - Theriogenology and developments in epidemiology: future opportunities?
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  AANA journal     Volume:  78     ISSN:  0094-6354     ISO Abbreviation:  AANA J     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-10-27     Completed Date:  2010-12-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0431420     Medline TA:  AANA J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  35-40     Citation Subset:  N    
R Adams Cowley Shock Trauma Center, Division of Trauma Amesthesiology, University of Maryland Medical Center, Baltimore, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acidosis / complications
Blood Coagulation Disorders / drug therapy*,  etiology*,  physiopathology
Brain Injuries / complications
Factor VIIa / therapeutic use*
Fever / complications
Fluid Therapy / adverse effects
Off-Label Use
Recombinant Proteins / therapeutic use
Shock, Hemorrhagic / complications
Wounds and Injuries / complications*
Reg. No./Substance:
0/Recombinant Proteins; 0/recombinant FVIIa; EC VIIa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nonopioid anesthesia for awake craniotomy: a case report.
Next Document:  Massive hemoptysis during monitored anesthesia care for esophagogastroduodenoscopy with percutaneous...